EMBC
Embecta Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Embecta Corp.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report4 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
No changes.
No changes.
No thesis.
Annual filing, covered
10-K parsed · Nov 25 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Nov 25 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
+26.29%
vs ±21.9% implied · ×1.20
shaded = implied · ▲▼ = realized
Embecta Corp.
6.10
−0.10 · −1.53%
post 6.10 0.00%
Largest filed tie
14.00%
of EMBC revenue · Five largest retail pharmacies
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Embecta Corp.'s 6 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Embecta Corp.'s 6 closest co-movers, none share that code.
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $15.0M | 9.13% | −49.82% |
| Yacktman | $14.1M | 8.56% | +17.54% |
| Vanguardindex-like | $8.3M | 5.07% | −0.27% |
| Deerfield | $8.3M | 5.03% | 0.00% |
| Leucadia National | $7.7M | 4.67% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| BlackRockindex-like | $15.0M | 9.13% | −49.82% |
| Yacktman | $14.1M | 8.56% | +17.54% |
| Vanguardindex-like | $8.3M | 5.07% | −0.27% |
| Deerfield | $8.3M | 5.03% | 0.00% |
| Leucadia National | $7.7M | 4.67% | 0.00% |
Bull1
Bear1
Tall tick = annual report · Source: EDGAR
Expected move
No implied move.